In this issue
The cholesterol and calorie hypotheses are both dead — it is time to focus on the real culprit: insulin resistance
Emerging evidence shows that insulin resistance is the most important predictor of cardiovascular and type 2 diabetes.
Non-alcoholic fatty liver disease is the term for a range of conditions caused by a build-up of fat in the liver. The condition is thought to be highly prevalent; however, the dearth of symptoms during early disease and the lack of a specific diagnostic test make it difficult to detect and manage at an early stage. This presents a considerable challenge for healthcare professionals.
Chronic hepatitis B and C infection are leading causes of liver-related morbidity and mortality worldwide. Current therapies for chronic hepatitis B virus (HBV) infection consisting of nucleos(t)ide analogues (NA) rarely lead to functional cure. With a better understanding of the HBV lifecycle, novel agents have been developed with the hope of achieving functional cure. The development of direct-acting antivirals (DAAs) for hepatitis C virus (HCV) therapy has led to ...
The Joint Committee for Vaccine and Immunisation (JCVI) has recently announced that the vaccine that could stop people from dying from human papilloma virus (HPV)-related cancers will not be given to boys (The Pharmaceutical Journal online, 20 July 2017).
Charcoal toothpastes: what we know so farSubscription
Charcoal toothpastes are a recent innovation in the oral healthcare product market, and some pharmacies have started stocking them. The marketing campaigns for these toothpastes are fashionable, trendy, and different to those for other toothpastes. This marketing has enjoyed considerable success, encouraging the introduction of related products, including ‘charcoal toothbrushes’, which have charcoal incorporated into the bristles.
As pharmacy moves forward, there will no doubt be necessary changes to the undergraduate pharmacy curriculum. However, we must ensure that the foundation knowledge that all pharmacists should have is not compromised. The pharmacist, in some instances, is all that stands between the patient and harm from their medicines. This may mean counselling in the correct use of their medicines, but it also means knowing the limitations of types of dosage forms.
Experience of setting up and running a referral scheme from the secondary care anticoagulant clinic to community pharmacies in SwindonSubscription
The new medicines service (NMS) is an advanced service in the community pharmacy contractual framework. It consists of community pharmacist structured interviews with patients during their first month of treatment with a new medicine. The service aims to improve medicines concordance and improve patient understanding of their treatment.